Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21
Phase 32

Trial Status

Completed3
Terminated3

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

Research Network

Collaboration Network

66 collaborators·110 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Joseph Kiss, MD

University of Pittsburgh

Moderately Similar
3 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopeniaPurpura, Thrombotic Thrombocytopenic

Worked with same sponsors:

Carelon ResearchGenentech, Inc.+1 more
Collaborated on 3 trials
Similarity Score42%

David Kuter, MD

Massachusetts General Hospital

Moderately Similar
5 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopeniaPurpura, Thrombotic Thrombocytopenic

Worked with same sponsors:

Carelon ResearchGenentech, Inc.+1 more
Collaborated on 3 trials
Similarity Score42%

Cindy Leissinger, MD

Tulane University

Moderately Similar
4 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopeniaPurpura, Thrombotic Thrombocytopenic

Worked with same sponsors:

Carelon ResearchGenentech, Inc.+1 more
Collaborated on 3 trials
Similarity Score42%

Thomas Ortel, MD

Duke University

Related
4 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicPurpura, Thrombotic Thrombocytopenic

Worked with same sponsors:

Carelon ResearchGenentech, Inc.+1 more
Collaborated on 2 trials
Similarity Score28%

Barbara Konkle, MD

University of Pennsylvania

Related
3 trials

Shared therapeutic areas:

ThrombocytopeniaPurpura, Thrombotic Thrombocytopenic

Worked with same sponsors:

Carelon ResearchGenentech, Inc.+1 more
Collaborated on 2 trials
Similarity Score28%

Judith Lin, MD

Brigham and Women's Hospital

Related
3 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score28%

Ann Zimrin, MD

University of Maryland

Related
2 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score28%

Terry Gernsheimer, MD

University of Washington

Related
4 trials

Shared therapeutic areas:

ThrombocytopeniaPurpura, Thrombocytopenic, Idiopathic

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score28%

Alexis Thompson, MD

Children's Memorial Hospital of Chicago

Related
2 trials

Shared therapeutic areas:

beta-ThalassemiaThalassemia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score24%

Mark Brecher, MD

University of North Carolina, Chapel Hill

Related
1 trials

Shared therapeutic areas:

Purpura, Thrombotic Thrombocytopenic

Worked with same sponsors:

Carelon ResearchGenentech, Inc.+1 more
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT00331006Phase 2PrincipalInvestigator

Rituximab to Treat Severe Hemophilia A

Hemophilia A
Completed
NCT00594685PrincipalInvestigator

Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study)

Thrombocytopenia
Terminated
NCT00799773Phase 3PrincipalInvestigator

Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP)

Thrombotic Thrombocytopenic Purpura
Terminated
NCT00872339PrincipalInvestigator

Assessment of Pain in People With Thalassemia

Thalassemia
Completed
NCT00991939Phase 3PrincipalInvestigator

Initial Treatment of Patients With Immune Thrombocytopenic Purpura

Immune Thrombocytopenic Purpura
Terminated
NCT01039636Phase 1PrincipalInvestigator

Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload

Beta-thalassemiaTransfusional Iron Overload
Completed

All 6 trials loaded